Everything You Need to Know About Paxlovid — Especially, Should You Take It?
Even as specialists in infectious diseases praise the treatment’s effectiveness, many doctors say they have questions about prescribing the drug and want better data.
Michelle Andrews of Kaiser Health News
Why So Slow? Legislators Take On Insurers’ Delays In Approving Prescribed Treatments
A dozen states have passed broad reforms to un-gum delays in billing, a process that is notoriously sticky.
Officials Struggle To Regulate Pop-Up COVID Testing Sites — And Warn Patients To Beware
Mobile COVID-19 testing tents and vans have sprouted on urban sidewalks and street curbs, sparking concerns about risks.
As Workers Struggle, Employers Expand Mental Health Benefits
In a recent survey, Kaiser Family Foundation found that many employers have ramped up mental health and other benefits to provide support for their workers during uncertain times.
Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough To Switch?
Medical professionals look to biosimilar drugs as a way to increase competition and give consumers cheaper options, but doctors and patients are raising concerns.
